Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Shares Outstanding: 2024-2025

Historic Shares Outstanding for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $87.0 million.

  • Kura Oncology's Shares Outstanding rose 11.92% to $87.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.0 million, marking a year-over-year increase of 11.92%. This contributed to the annual value of $78.2 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Kura Oncology's Shares Outstanding stood at $87.0 million, which was up 0.25% from $86.8 million recorded in Q2 2025.
  • Kura Oncology's Shares Outstanding's 5-year high stood at $87.0 million during Q3 2025, with a 5-year trough of $76.2 million in Q1 2024.